Sulfonylureas and ischemic heart disease.
Matz
R
R
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000209:etiology; D005905:Glyburide / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D017202:Myocardial Ischemia / Q000139:chemically induced* / Q000150:complications; D015221:Potassium Channels / Q000187:drug effects*; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D007004:Hypoglycemic Agents; D015221:Potassium Channels; D013453:Sulfonylurea Compounds; D005905:Glyburide